Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) lost ground on Tuesday after a debt conversion sparked equity dilution concerns across its shareholder base. The tissue engineering, lab-grown materials, and bioactive solutions developer fell 10.56% to 1.12p in morning London trade as the market...
BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) has signed heads of terms for the worldwide exclusive commercialisation of its proprietary ETSYL® bioactive peptide across the cosmetics, skincare, dermocosmetics and luxury beauty markets. The agreement with Germany-based SCHAKAU Managementberatung...
Shares in BSF Enterprise PLC (LSE:BSFA, OTC:BSFAF) soared 56.5% to 1.33p on Monday after the tissue engineering company agreed outline terms for a joint venture to sell its lab-grown leather into the American luxury market. The London-listed group has signed non-binding heads of terms with...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.